Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
Decoy Therapeutics announced that members of its executive leadership will present at two peptide therapeutics conferences in Boston during the week of April 27. CBO Peter Marschel will lead a roundtable at the Oligonucleotide & Peptides HubXchange, while CSO Dr. Barbara Hibner and CTO Dr. Michael Lipp will present new preclinical data at the Peptide-Based Therapeutics Summit.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.